AstraZeneca says U.S. FDA grants fast track status for diabetes drug Farxiga

AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with long-term kidney disease.

from Reuters: Health News https://ift.tt/2ZvU48I
via IFTTT